↓ Skip to main content

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2014
Altmetric Badge

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
Published in
Neuropsychiatric Disease and Treatment, August 2014
DOI 10.2147/ndt.s68951
Pubmed ID
Authors

Robert L Findling, Lawrence D Ginsberg

Abstract

To assess the safety and effectiveness of open-label treatment with extended-release carbamazepine (ERC) in pediatric subjects suffering from bipolar I disorder.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 15%
Student > Postgraduate 6 11%
Student > Doctoral Student 5 9%
Other 4 8%
Researcher 4 8%
Other 10 19%
Unknown 16 30%
Readers by discipline Count As %
Medicine and Dentistry 17 32%
Psychology 12 23%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Immunology and Microbiology 1 2%
Social Sciences 1 2%
Other 3 6%
Unknown 17 32%